Dashboard
Manage Tickers

JAZZ


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

jazz-pharmaceuticals-announced-updated-data-including-median-progression-free-survival-and-overall-survival-findings-from-the-phase-2-trial-of-zanidatamab-in-combination-with-chemotherapy-as-first-line-treatment-for-her2-expressing-advanced-or-metastatic-gastroesophageal-adenocarcinoma
Jazz Pharmaceuticals Announced Updated Dat...
09/16/2024 11:35:26

needham-reiterates-buy-on-jazz-pharmaceuticals-maintains-205-price-target
Needham Reiterates Buy on Jazz Pharmaceuti...
09/10/2024 09:37:51

Needham analyst Ami Fadia reiterates Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Buy and maintains $205 price target.

a-closer-look-at-12-analyst-recommendations-for-jazz-pharmaceuticals
A Closer Look at 12 Analyst Recommendation...
09/09/2024 18:01:57

cantor-fitzgerald-reiterates-overweight-on-jazz-pharmaceuticals-maintains-140-price-target
Cantor Fitzgerald Reiterates Overweight on...
09/09/2024 15:43:22

Cantor Fitzgerald analyst Charles Duncan reiterates Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Overweight and maintains $140 ...

jazz-pharmaceuticals-highlights-zanidatamab-and-zepzelca-cancer-trials-at-esmo-congress
Jazz Pharmaceuticals Highlights Zanidatama...
09/09/2024 12:00:36

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) today announced that the Company, along with its partners, will present five abstracts a...

jazz-pharmaceuticals-launches-850m-senior-notes-offering-and-kicks-off-share-buyback-strategy
Jazz Pharmaceuticals Launches $850M Senior...
09/04/2024 06:04:38

The notes will be general unsecured obligations of the Issuer and will accrue interest payable semiannually in arrears on March...

jazz-intends-to-offer-850m-of-exchangeable-senior-notes-due-2030-in-private-offering-plans-concurrent-ordinary-share-repurchases-up-to-150m-of-its-ordinary-shares
Jazz Intends To Offer $850M Of Exchangeabl...
09/03/2024 11:02:54

Jazz Pharmaceuticals, together with its consolidated subsidiaries, expects to use a portion of the net proceeds to prepay up to...

jazz-and-hikma-accused-of-delaying-sleep-disorder-generic-drug-to-maintain-high-prices
Jazz And Hikma Accused Of Delaying Sleep D...
08/28/2024 17:37:50

Jazz Pharmaceuticals and Hikma Pharmaceuticals will face trial over allegations of delaying a generic version of Xyrem, causing...

from-five-minutes-of-agony-its-now-just-seconds-says-brazilian-mother-celebrating-free-access-to-her-childs-life-saving-cbd-medicine
'From Five Minutes Of Agony, It's Now Just...
08/28/2024 01:11:55

the-only-fda-approved-cbd-treatment-for-severe-epilepsy-completes-key-phase-3-trial-in-japan-despite-missed-primary-goal
The Only FDA-Approved CBD Treatment For Se...
08/23/2024 13:15:58

jazz-pharmaceuticals-provides-update-on-cannabidiol-oral-solution-phase-3-trial-in-japan-in-treatment-resistant-epilepsies
Jazz Pharmaceuticals Provides Update On Ca...
08/22/2024 20:11:40

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) today announced top-line results from the Phase 3 open-label, single-arm trial in Japan ...

a-closer-look-at-12-analyst-recommendations-for-jazz-pharmaceuticals
A Closer Look at 12 Analyst Recommendation...
08/19/2024 14:00:54

jp-morgan-maintains-overweight-on-jazz-pharmaceuticals-raises-price-target-to-202
JP Morgan Maintains Overweight on Jazz Pha...
08/19/2024 13:14:23

JP Morgan analyst Jessica Fye maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Overweight and raises the price target fro...

decoding-11-analyst-evaluations-for-jazz-pharmaceuticals
Decoding 11 Analyst Evaluations For Jazz P...
08/01/2024 17:03:43

cantor-fitzgerald-reiterates-overweight-on-jazz-pharmaceuticals-maintains-140-price-target
Cantor Fitzgerald Reiterates Overweight on...
08/01/2024 16:52:13

Cantor Fitzgerald analyst Charles Duncan reiterates Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Overweight and maintains $140 ...

piper-sandler-maintains-overweight-on-jazz-pharmaceuticals-lowers-price-target-to-166
Piper Sandler Maintains Overweight on Jazz...
08/01/2024 15:58:39

Piper Sandler analyst David Amsellem maintains Jazz Pharmaceuticals (NASDAQ: JAZZ) with a Overweight and lowers the price ta...

rbc-capital-maintains-outperform-on-jazz-pharmaceuticals-lowers-price-target-to-174
RBC Capital Maintains Outperform on Jazz P...
08/01/2024 15:31:22

RBC Capital analyst Gregory Renza maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Outperform and lowers the price target...

wells-fargo-maintains-equal-weight-on-jazz-pharmaceuticals-lowers-price-target-to-120
Wells Fargo Maintains Equal-Weight on Jazz...
08/01/2024 13:42:07

Wells Fargo analyst Mohit Bansal maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Equal-Weight and lowers the price targe...

needham-maintains-buy-on-jazz-pharmaceuticals-lowers-price-target-to-205
Needham Maintains Buy on Jazz Pharmaceutic...
08/01/2024 12:29:40

Needham analyst Ami Fadia maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Buy and lowers the price target from $208 to $...

hc-wainwright--co-reiterates-buy-on-jazz-pharmaceuticals-maintains-200-price-target
HC Wainwright & Co. Reiterates Buy on Jazz...
08/01/2024 12:18:10

HC Wainwright & Co. analyst Oren Livnat reiterates Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Buy and maintains $200 pric...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION